The opioid abuse epidemic is a major health concern that requires new pain management strategies. Findings now show that suvorexant, a dual hypocretin receptor antagonist, reverses the anatomical and circuit alterations induced by opioids and decreases addictive behavior while maintaining the analgesic properties of the drugs.
- Jimmy J. Fraigne
- John H. Peever